CIBC Bancorp USA’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
CIBC Bancorp USA's AMGN Position: Q3 2026 in Review
CIBC Bancorp USA reduced its Amgen (AMGN) stake by 17% in Q3 2026, selling an estimated $36.7M and leaving 437,527 shares worth $184M. The position accounts for 0.23% of the portfolio, ranked #106.
CIBC Bancorp USA first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $192M in Q1 2026. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- CIBC Bancorp USA held 437,527 shares of Amgen worth $184M as of Q3 2026.
- CIBC Bancorp USA sold 92,086 Amgen shares in Q3 2026, an estimated $36.7M.
- Amgen made up 0.23% of CIBC Bancorp USA's portfolio in Q3 2026, its #106 holding.
- CIBC Bancorp USA first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
- CIBC Bancorp USA's Amgen position peaked at $192M in Q1 2026.
- 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.